CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 38 enrolled
Drug / intervention
Multiple daily ijnection using Insulin Degludec and Insulin Aspartdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03987191
NCT03987191Phase 4Completed
CompareCT.gov

Successful Transition From Insulin Pump to Multiple Daily Injections Using Insulin Degludec in Adults With Type 1 Diabetes

University of Colorado, Denver·interventional·Posted Jun 14, 2019·Updated Sep 13, 2021

In Brief

A Phase 4 clinical trial evaluating Multiple daily ijnection using Insulin Degludec and Insulin Aspart for Type 1 Diabetes. Completed, enrolled 38 participants across 1 site.

Detailed Summary

This randomized controlled, two arms, investigator initiated, intervention study is aimed to examine an investigational approach in contrast to the clinical standard of 1:1 dose basal insulin conversion in an attempt to lower the incidence and/or duration of hyperglycemia after transition from insulin pump to multiple daily injections in adults with type 1 diabetes.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsType 1 Diabetes
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
2020202120222023202420252026
First PostedJun 14, 2019
Enrollment StartJan 10, 2020
Primary CompletionOct 8, 2020
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 7.0 years ago

Interventions

Multiple daily ijnection using Insulin Degludec and Insulin Aspartdrug

Drug: Insulin Degludec and insulin Aspart Pharmaceutical form: Solution for injection Route of administration: Subcutaneous